Lilly once-weekly diabetes drug proves superior in late-stage trials (Reuters, 22 June 2013)

24 Jun 2013


Eli Lilly and Co have announced that late-stage trials on their their once-weekly type 2 diabetes drug have shown better results in controlling blood sugar levels than similar medicines.  The results were presented at the American Diabetes Association meeting.

Full article


Share this story